FDA recall record

Coast Quality Pharmacy Macroaggregated albumin (MAA) kit recall — FDA D-0801-2018

Lack of Assurance of Sterility

Class IIclassification
D-0801-2018official record ID
May 16, 2018report date

Recall record at a glance

Official recordD-0801-2018
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmCoast Quality Pharmacy LLC
Report dateMay 16, 2018
Recall initiation dateApr 26, 2018
Quantity52 vials
LocationTampa, FL, United States

Official product description

Macroaggregated albumin (MAA) kit (for the preparation of Tc99m MAA), Aggregated and non-Aggregated Human Serum Albumin 2.5-5 mg Sodium Acetate Sol 200 mL/0.125 mL lyophilized powder in 10 mL glass vial, Rx only, AnazaoHealth, Tampa, FL

Why the product was recalled

Lack of Assurance of Sterility

Distribution information

AL, CA, FL, MI, SC, TX

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.